Clinical Trial Update: EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing EC followed by docetaxel versus ET followed by capecitabine as adjuvant chemotherapy in node-positive operable breast cancer; study comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Cyclophosphamide (C) (cyclophosphamide)
• DOCETAXEL (DOCETAXEL)
• EC followed by Docetaxel
• ET followed by Capecitabine
• Epirubicin (E) (epirubicin)
• Epirubicin-Cyclophosphamide (EC)

Snippet

Sponsor: Spanish Breast Cancer Research Group | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2019-10-25